BackDaxor Overview

Daxor Other Liabilities

Daxor's other liabilities is $0.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$0.00
↓ 100.00% YoYΔ $-840296.00 vs prior year quarter

Peer average

Loading

Daxor Other Liabilities History

Loading

Daxor vs. peers: Other Liabilities Comparison

Loading

Daxor Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Daxor (DXR) FAQ

As of the most recent data (December 2025), DXR shows a other liabilities of $0. That compares with $840K in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, DXR's other liabilities is now $0 (was $840K) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Daxor is outperforming or lagging.

Tracking DXR's other liabilities over time shows whether Daxor is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $840K in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other liabilities page, Stockcircle has Daxor's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other liabilities (currently $0) with ownership activity and broader fundamentals.

Daxor's other liabilities is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.